These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth. O'Rear L, Longobardi L, Torello M, Law BK, Moses HL, Chiarelli F, Spagnoli A. J Mol Endocrinol; 2005 Jun 05; 34(3):723-37. PubMed ID: 15956343 [Abstract] [Full Text] [Related]
3. TGF-beta control of cell proliferation. Huang SS, Huang JS. J Cell Biochem; 2005 Oct 15; 96(3):447-62. PubMed ID: 16088940 [Abstract] [Full Text] [Related]
4. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells. Kuemmerle JF, Murthy KS, Bowers JG. Am J Physiol Gastrointest Liver Physiol; 2004 Oct 15; 287(4):G795-802. PubMed ID: 15178549 [Abstract] [Full Text] [Related]
5. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. Rosendahl AH, Forsberg G. Kidney Int; 2006 Nov 15; 70(9):1584-90. PubMed ID: 16969385 [Abstract] [Full Text] [Related]
6. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells. Huo YY, Hu YC, He XR, Wang Y, Song BQ, Zhou PK, Zhu MX, Li G, Wu DC. Cell Biol Toxicol; 2007 Mar 15; 23(2):113-28. PubMed ID: 17096210 [Abstract] [Full Text] [Related]
7. Transforming growth factor-{beta} (TGF{beta}) receptors I/II differentially regulate TGF{beta}1 and IGF-binding protein-3 mitogenic effects in the human placenta. Forbes K, Souquet B, Garside R, Aplin JD, Westwood M. Endocrinology; 2010 Apr 15; 151(4):1723-31. PubMed ID: 20172969 [Abstract] [Full Text] [Related]
8. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration. Fu P, Liang GJ, Khot SS, Phan R, Bach LA. J Cell Physiol; 2010 Sep 15; 224(3):636-43. PubMed ID: 20432455 [Abstract] [Full Text] [Related]
9. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG. Oncogene; 2003 Jul 10; 22(28):4314-32. PubMed ID: 12853969 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-beta- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell cultures. Kamanga-Sollo E, Pampusch MS, White ME, Hathaway MR, Dayton WR. Exp Cell Res; 2005 Nov 15; 311(1):167-76. PubMed ID: 16214131 [Abstract] [Full Text] [Related]
11. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line. Park HJ, Kim BC, Kim SJ, Choi KS. Hepatology; 2002 Jun 15; 35(6):1360-71. PubMed ID: 12029621 [Abstract] [Full Text] [Related]
12. TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Chen G, Khalil N. Respir Res; 2006 Jan 03; 7(1):2. PubMed ID: 16390551 [Abstract] [Full Text] [Related]
13. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor. Yue J, Sun B, Liu G, Mulder KM. J Cell Physiol; 2004 May 03; 199(2):284-92. PubMed ID: 15040011 [Abstract] [Full Text] [Related]